Log in

Relevant bibliographies by topics / Fasting Blood Sugar; Postprandial Blood Sugar

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers

Academic literature on the topic 'Fasting Blood Sugar; Postprandial Blood Sugar'

Author: Grafiati

Published: 5 June 2025

Last updated: 25 June 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Fasting Blood Sugar; Postprandial Blood Sugar.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Fasting Blood Sugar; Postprandial Blood Sugar"

1

Herath, H. M. M., T. P. Weerarathna, C. L. Fonseka, and A. S. Vidanagamage. "Targeting postprandial blood sugar over fasting blood sugar: A clinic based comparative study." Diabetes & Metabolic Syndrome: Clinical Research & Reviews 11, no. 2 (2017): 133–36. http://dx.doi.org/10.1016/j.dsx.2016.06.029.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Roshan, Bhandari, Bahadur KC Ram, G. C. Bijay, et al. "Investigating Diabetic Retinopathy (DR) among individuals with Type 2 Diabetes Mellitus (T2DM)." World Journal of Advanced Research and Reviews 19, no. 2 (2023): 1484–92. https://doi.org/10.5281/zenodo.10852891.

Full text

Abstract:

<strong>Background:</strong> Diabetic retinopathy (DR) is a sight-threatening complication of type 2 diabetes mellitus (T2DM). Understanding its occurrence and associated factors is crucial for prevention and management. This study aimed to investigate DR in T2DM patients and identify relevant factors. <strong>Methods:</strong> A 14-month hospital-based cross-sectional study was conducted at Bir Hospital, Kathmandu. Sixty T2DM patients were included, undergoing ocular examinations and fundus evaluations at Nepal Eye Hospital. DR severity was graded using the Early Treatment Diabetic Retinopathy Study (ETDRS) criteria. HbA1C levels, fasting, and postprandial blood sugar were measured. Statistical analysis included chi-square test, t-test, and logistic regression. <strong>Results:</strong> DR patients had a lower mean age (55.57±9.79 years) compared to non-DR patients (58.00±12.038 years, p=0.12). Age inversely correlated with severe DR (aOR=0.94, p=0.02). Longer diabetes duration increased DR likelihood (aOR=1.23, p=0.001) and severe DR risk (aOR=1.2, p<0.0001). Mean HbA1c was higher in DR patients (8.22±1.61%) compared to non-DR patients (7.48±1.59%, p=0.08), with marginal significance (aOR=1.44, p=0.09). Postprandial blood sugar was associated with DR (aOR=1.01, p=0.033), while fasting blood sugar was not significant. Hypertension was not associated with DR (p=0.89). <strong>Conclusion:</strong> This study reveals higher prevalence and severity of DR with longer diabetes duration. Postprandial blood sugar showed significant association with DR, while fasting blood sugar did not. HbA1c's relationship with DR was marginally significant. Effective glycemic control and regular DR screening are crucial in T2DM patients.

APA, Harvard, Vancouver, ISO, and other styles

3

Adak, Manoranjan, and Hari Prasad Upadhyay. "Influence of Aging on HbA1C: A Cross-Sectional Study on Diabetic Population Attending a Tertiery Care Center of Central Nepal." Journal of College of Medical Sciences-Nepal 18, no. 3 (2022): 227–34. http://dx.doi.org/10.3126/jcmsn.v18i3.45504.

Full text

Abstract:

Background: Diabetes mellitus is increasing day by day throughout the globe. So, early diagnosis of diabetes is crucially important in reduction of the complications. This study was conducted to determine the correlation between glucose monitoring by fasting blood glucose and two hours postprandial blood glucose with glycated hemoglobin (HbA1c) in diabetic patients and evaluate whether glycohemoglobin levels increase with age in both sexes Methods: A hospital-based analytical cross-sectional study was carried out from March 2020 to December 2021 in diabetic patients attending at outpatient department (OPD) of College of Medical College and Teaching Hospital, Bharatpur, Chitwan. The total number patients was 696 people. HbA1c, fasting blood sugar (FBS) and postprandial blood sugar (PPBS) were analyzed. Results: Both postprandial blood glucose and fasting blood glucose significantly correlated with HbA1c. Postprandial blood glucose showed better correlation to HbA1c than fasting blood glucose (r = 0.630, P <0.001 vs. r =0.452, P = 0.05). Conclusions: These results show that postprandial blood glucose correlated better than fasting blood glucose to HbA1c. Thus, postprandial blood glucose predicted overall glycemic control better than fasting blood glucose. Based on our study, we may concluded a significant correlation exist between age and HbA1c in Nepalese population.

APA, Harvard, Vancouver, ISO, and other styles

4

Salih, Banaz Abed, Himan Ibrahim Ali, and Shireen Hosny Ramadhan. "A Comparative Study on the Impact of Fasting on Blood Glucose and Blood Pressure Among Diabetic and Non-Diabetic Individuals During Ramadan, Kurdistan Region, Iraq." Technium BioChemMed 10 (October 31, 2024): 58–82. http://dx.doi.org/10.47577/biochemmed.v10i.11918.

Full text

Abstract:

Objective: The primary aim of this research was to evaluate the differential effects of regular and fasting dietary patterns on blood glucose levels and blood pressure among diabetic patients and non-diabetic control group. A comprehensive analysis was conducted to compare physiological responses on fasting versus non-fasting days during the holy Ramadan month. Methods: This observational study involved 92 participants, with a subset of 38 diabetic patients and 54 non-diabetic control group, aged 19-76 years, who were observed on regular and fasting days. Participants were monitored for pre-prandial, postprandial, evening blood sugar, and fasting blood glucose levels, as well as blood pressure. Statistical analysis was performed using paired sample t-tests to compare mean ± SD between regular and fasting days of both groups. The study cohort consisted of male and female adults diagnosed with type 1 or type 2 diabetes. Exclusion criteria included individuals under 18 years, pregnant women, and patients unable to fast during the study period. Results: Statistical analysis revealed significant differences in fasting blood glucose levels during Ramadan compared to non-fasting days. In the diabetic group, significant changes were observed in fasting blood glucose levels during Ramadan compared to after Ramadan ( postprandial blood sugar p=0.04, evening blood sugar p=0.019). In contrast, the non-diabetic group also showed significant changes in blood glucose levels during Ramadan compared to after Ramadan (postprandial blood sugar p=0.001, evening blood sugar p=0.020). Blood pressure showed no significant differences between these periods, suggesting that fasting does not alter blood pressure significantly in diabetic individuals. Additionally, a two-way ANOVA demonstrated significant dietary influences on post-Iftar glucose levels in non-diabetics (p<0.001), but not in diabetics, suggesting differential metabolic responses to dietary intake during Ramadan. These findings emphasize the critical need for personalized dietary management and continuous monitoring to optimize diabetic care during fasting. Conclusion: Fasting significantly influences blood glucose levels in diabeticand non-diabetic individuals but does not affect blood pressure. This study underscores the necessity for personalized medical guidance and balanced meal planning to minimize complications and enhance diabetes management during fasting. Further research is warranted to explore the long-term effects of different fasting practices on diabetic health outcomes.

APA, Harvard, Vancouver, ISO, and other styles

5

Roshan Bhandari, Ram Bahadur KC, Bijay G C, et al. "Investigating Diabetic Retinopathy (DR) among individuals with Type 2 Diabetes Mellitus (T2DM)." World Journal of Advanced Research and Reviews 19, no. 2 (2023): 1484–92. http://dx.doi.org/10.30574/wjarr.2023.19.2.1734.

Full text

Abstract:

Background: Diabetic retinopathy (DR) is a sight-threatening complication of type 2 diabetes mellitus (T2DM). Understanding its occurrence and associated factors is crucial for prevention and management. This study aimed to investigate DR in T2DM patients and identify relevant factors. Methods: A 14-month hospital-based cross-sectional study was conducted at Bir Hospital, Kathmandu. Sixty T2DM patients were included, undergoing ocular examinations and fundus evaluations at Nepal Eye Hospital. DR severity was graded using the Early Treatment Diabetic Retinopathy Study (ETDRS) criteria. HbA1C levels, fasting, and postprandial blood sugar were measured. Statistical analysis included chi-square test, t-test, and logistic regression. Results: DR patients had a lower mean age (55.57±9.79 years) compared to non-DR patients (58.00±12.038 years, p=0.12). Age inversely correlated with severe DR (aOR=0.94, p=0.02). Longer diabetes duration increased DR likelihood (aOR=1.23, p=0.001) and severe DR risk (aOR=1.2, p<0.0001). Mean HbA1c was higher in DR patients (8.22±1.61%) compared to non-DR patients (7.48±1.59%, p=0.08), with marginal significance (aOR=1.44, p=0.09). Postprandial blood sugar was associated with DR (aOR=1.01, p=0.033), while fasting blood sugar was not significant. Hypertension was not associated with DR (p=0.89). Conclusion: This study reveals higher prevalence and severity of DR with longer diabetes duration. Postprandial blood sugar showed significant association with DR, while fasting blood sugar did not. HbA1c's relationship with DR was marginally significant. Effective glycemic control and regular DR screening are crucial in T2DM patients.

APA, Harvard, Vancouver, ISO, and other styles

6

R.P., Vinodkumar, Ravisekar* P., and Kalaiselvi R. "Correlation of Serum Ferritin with HbA1c Levels in Type 2 Diabetes Mellitus." International Journal of Pharmaceutical and Clinical Research 16, no. 2 (2024): 613–16. https://doi.org/10.5281/zenodo.11072865.

Full text

Abstract:

<strong>Background:</strong> Diabetes is a metabolic disorder characterized by hyperglycemia which is associated with rise in the HbA1c levels. Excess iron damages β-cells of pancreas due to oxidative stress which can contribute to pathogenesis of diabetes mellitus. Serum ferritin, an acute phase reactant a marker of iron stores in the body and its level is considered to be an indicator of body iron stores. <strong>Objective:</strong> 1. To assess the serum ferritin, FBS, PPBS and HbA1c level in type 2 diabetes mellitus patients. 2. To find the correlation of serum ferritin with FBS, PPBS and HbA1c levels in this patients. <strong>Material and Methods</strong>: This study was performed in 100 Diabetic Patients attending Dialectology OPD in Government Mohan kumaramangalam medical college and hospital and 5ml of venous blood sample will be collected and analysed Blood sugar in fully automated chemistry analyser and HbA1c in D10 analyser and ferritin in chemiluminescent immunosorbant method. The statistical analysis was performed using SPSS version 16. <strong>Results:</strong> There was a positive correlation between serum ferritin and Fasting sugar, postprandial sugar, HbA1c. Serum ferritin is significantly related to Fasting Sugar (P value- 0.000013) moderate positive correlation; postprandial sugar (P value- 0.00001) a moderately strong positive correlation and glycated Hemoglobin (P value-0.00001) moderate positive correlation. <strong>Conclusion:</strong> The serum ferritin level increased in patients with type 2 diabetes mellitus and there is Positive correlation between HbA1c and serum ferritin has also been found. It indicates that in low resource setting serum ferritin can be used as a marker for glycemic control in diabetic patients it is cost effective compared to HBA1C screening.    

APA, Harvard, Vancouver, ISO, and other styles

7

Kadiyala, Sri Ramulu, Karthik Rao, Nr Rao, et al. "ASSOCIATION OF POSTPRANDIAL BLOOD SUGAR WITH HYPERCOAGULABILITY IN COMPARISON TO FASTING BLOOD SUGARS IN DIABETIC AND HEALTHY PATIENTS: A CROSS-SECTIONAL STUDY." Asian Journal of Pharmaceutical and Clinical Research 10, no. 7 (2017): 378. http://dx.doi.org/10.22159/ajpcr.2017.v10i7.18806.

Full text

Abstract:

Objective: The aim of this study was to find the association of postprandial blood glucose with hypercoagulability in comparison to fasting blood sugars(FBS) in diabetic and healthy patients.Methods: The present study involved a total of 156 patients, of which 78 were taken as cases (diabetics) and other 78 as controls (non-diabetics). Laboratory analysis included prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen assay done along with fasting, and postprandial sugars.Results: Platelets in diabetics and healthy controls were in normal range. Decrease in PT and partial thromboplastin time was noted in diabetics compared to non-diabetic controls. Fibrinogen levels were increased in cases compared to controls. Changes in PT values were more significant with postprandial blood sugar (PPBS) levels when compared to FBS levels, and APTT follows the same pattern with more in PPBS levels and FBS levels in diabetics. PPBS showed elevated fibrinogen when compared to FBS in diabetics as well as non-diabetics.Conclusion: Type 2 diabetes mellitus is a hypercoagulable state as proven by the following results of our study.

APA, Harvard, Vancouver, ISO, and other styles

8

Vinay, Kumar Sinha, Haider Tauseef, and Kumar Jeetendra. "Efficacy and Safety of Metformin and Vildagliptin versus Metformin and Glimepiride in Patients of Type 2 Diabetes Mellitus: A Comparative Study." International Journal of Pharmaceutical and Clinical Research 16, no. 4 (2024): 896–901. https://doi.org/10.5281/zenodo.11180204.

Full text

Abstract:

<strong>Background:</strong> The main feature of diabetes mellitus, a varied chronic metabolic illness, is persistent hypergly-cemia brought on by abnormalities in insulin secretion or activity. Over time, persistent hyperglycemia and related metabolic abnormalities cause tissue damage that shows up as accelerated atherosclerosis, renoretinal microangiopathy, and neuropathy, which can result in a range of localized, vascular, and neurological problems. The present study aims to compare the safety and effectiveness of metformin and vildagliptin with metformin and glimepiride in individuals with Type 2 diabetes. <strong>Methods:</strong> This study is an interventional longitudinal type. The study involved the enrollment of sixty patients in total. The trial comprised patients with poor glycemic control who were currently on 500 mg of metformin daily. These sixty patients were divided up into two groups of thirty each. Patients in Group A were given 500 mg of metformin and 1 mg of glimepiride daily. Patients in Group B were given 500 mg of metformin and 50 mg of vildagliptin bid. The trial lasted for three months in total. <strong>Results:</strong> Following three months of therapy, there was a significant decrease in blood glucose levels in both the postprandial (PPBS) and fasting (FBS) groups. The two groups differed significantly in their ability to lower the PPBS and FBS levels. After 12 weeks, there was a notable decrease in both groups’ hemoglobin A1c (HbA1c). Following three months of treatment, the group B HbA1C decreased. Between the two groups, there was no statistically significant difference in the HbA1C reduction. After three months of treatment, the group taking metformin and glimepiride experienced more adverse effects. The frequency of negative effects varied significantly between the two groups. <strong>Conclusion:</strong> Vildagliptin and metformin combined produced a better adverse effect profile with a lower risk of hypoglycemia and weight gain, and their efficacy was comparable to that of glimepiride and metformin together.    

APA, Harvard, Vancouver, ISO, and other styles

9

Shrestha, L., B. Jha, B. Yadav, and S. Sharma. "Correlation between fasting blood glucose, postprandial blood glucose and glycated hemoglobin in non-insulin treated type 2 diabetic subjects." Sunsari Technical College Journal 1, no. 1 (2013): 18–21. http://dx.doi.org/10.3126/stcj.v1i1.8654.

Full text

Abstract:

Background: Diabetes mellitus (DM) comprises a group of common metabolic disorders that share phenotype of hyperglycemia. Objectives: This study was conducted to determine the correlation between glucose monitoring by fasting blood glucose or two hours postprandial blood glucose with glycated hemoglobin (HbA1c) in type 2 diabetic patients. Method: A cross sectional study was conducted over a period of six month in the Department of Biochemistry. Institute of Medical, Tribhuvan University Teaching Hospital. Sixty inpatients with Diabetes mellitus type 2 were assessed for daily fasting and postprandial blood sugar for 15 consecutive days. HbA1c was measured on the 15th day. Result: Both postprandial blood glucose and fasting blood glucose significantly correlated with HbA1c. Postprandial blood glucose showed better correlation to HbA1c than fasting blood glucose (r = 0.630, P <0.001 vs. r =0.452, P = 0.05). Conclusion: These results show that postprandial blood glucose correlated better than fasting blood glucose to HbA1c. Thus, postprandial blood glucose predicted overall glycemic control better than fasting blood glucose. This finding has potential implications for treatment and monitoring of metabolic control in type-2 diabetes. DOI: http://dx.doi.org/10.3126/stcj.v1i1.8654 Sunsari Technical College Journal Vol.1(1) 2012 18-21

APA, Harvard, Vancouver, ISO, and other styles

10

Silalahi, Lenny Erida, Diana Irawati, Dewi Anggraeni, Wati Jumaiyah, and Rika Mustika Abriyanti. "Penerapan Intervensi Edukasi terhadap Self-Management, Self Efficacy dan Nilai Gula Darah pada Pasien Diabetes Melitus." Journal of Telenursing (JOTING) 5, no. 2 (2023): 3745–53. http://dx.doi.org/10.31539/joting.v5i2.7929.

Full text

Abstract:

This study aims to implement Evidence-Based Nursing Practice (EBNP) with educational interventions on self-management, self-efficacy, and blood sugar values in DM patients at Tarakan Hospital, Jakarta. This research method uses quasi-experimental. The research results show that the p-value of self-management with self-efficacy is (r=0.464, p=0.001). The conclusion is that fasting blood sugar changes will impact postprandial blood sugar changes, and self-management will influence changes in respondents' self-efficacy.  Keywords: DM, Self-management, Self-efficacy

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Fasting Blood Sugar; Postprandial Blood Sugar"

1

Gragg, MaryAnne G. "The apparent increase in insulin sensitivity of leptin-treated rats appears to be due to a decrease in blood glucose concentrations in response to fasting l." Auburn, Ala., 2007. http://repo.lib.auburn.edu/07M%20Theses/GRAGG_MARYANNE_23.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Behrendt, Marek, and Tommy Ivarsson. "Hunger indikerar inte akut energistatus hos friska människor : En måltidsintervention." Thesis, Högskolan i Halmstad, Sektionen för ekonomi och teknik (SET), 2012. http://urn.kb.se/resolve?urn=urn:nbn:se:hh:diva-18915.

Full text

Abstract:

Bakgrund En mer stillasittande livsstil med ett högre kaloriintag ökar riskerna för övervikt och andra metabola sjukdomar. För att förebygga och behandla dessa sjukdomar behöver vi bland annat förstå hur hungerkänslor regleras hos människan. Hur stor inverkan blodglukosnivåer har på hungerregleringen är dock omdiskuterat. Syfte Syftet med denna studie var att undersöka hur hungerkänslor och blodglukosnivåer förändras efter en måltid, jämfört med fasta. Kan den upplevda hungern påverkas genom periodisk fas-ta? Hur påverkar en invand måltidsrytm hungern? Hur påverkas hunger och blodglukos i för-väntan på en måltid? Metod Tolv friska testpersoner (7 män, 5 kvinnor) där sju stycken var vana vid periodisk fasta och fem inte var det, randomiserades in i två grupper där ena gruppen (Pi) fick äta en 600 kcal pizza medan den andra gruppen fick fasta (F). Blodglukosvärden och hungeruppskattningar registrerades var 30:e minut, förutom första värdet som registrerades 15 minuter innan pizzor-na serverades. Testpersonerna visste inte vilken grupp de skulle hamna i förrän 10 minuter innan pizzorna serverades. Resultat Fem timmar efter måltiden kunde ingen signifikant skillnad i blodglukossänkning observeras mellan grupperna. Hungern skiljde sig inte heller signifikant mellan grupperna. Endast Pi ökade dock signifikant i hunger (P = 0,05) jämfört med sina startvärden. Fastevana bidrog inte till en förbättrad hungerkontroll. Beskedet om vilken grupp testpersonerna skulle hamna i resulterade i att blodglukosnivåerna skiljde sig signifikant mellan grupperna (P = 0,05) när pizzorna serverades. Då sänktes blodglukosnivåerna hos Pi samtidigt som de höjdes hos F. Fyra av fem testpersoner i F och en testperson i Pi blev tydligt hungrigare vid tidpunkter då de vanligtvis brukade äta på. Slutsats Samband mellan absoluta blodglukosnivåer och hunger kunde inte hittas. Stark hunger kunde uppstå fastän dietär energi sannolikt fortfarande absorberades i tarmarna.Våra resultat indikerade därför att akut energitillgänglighet utgör en relativt liten del i den totala hungersignaleringen. En invand måltidsrytm såg ut att påverka hungern mer än vad måltiden i den här studien gjorde. Större fokus vid hungerreglering bör därför ligga på en re-gelbunden måltidsrytm.<br>Background The increasingly sedentary lifestyle of our society combined with a constantly rising caloric intake has elevated the risk of developing obesity and other metabolic diseases. There is a need to understand the underlying mechanisms of hunger regulation to effectively prevent and treat these diseases. The magnitude of which an active regulation of blood glucose has an influence on hunger regulation is rather controversial. Objective The objective of this study was to investigate how the changes in hunger and blood glucose levels may differ after a mixed meal compared to the fasting state. Research questions include: Does intermittent fasting reduce general hunger? How does an entrenched meal-pattern affect hunger? How does hunger and blood glucose change in anticipation of a meal? Method Twelve healthy subjects (7 men, 5 women), of which seven subjects regularly practiced intermittent fasting and the remaining five did not, were randomized into two groups, one group was eating pizza (Pi), and the other group was fasting (F). Blood glucose levels and hunger ratings were collected every 30 minutes, with exception of initial values that were collected 15 minutes prior to the serving of the pizzas. The subjects were unaware of which group they would be designated to until 10 minutes prior to the serving of the pizzas. Results Decline in blood glucose did not significantly differ between groups during the 5 hour window following the meal ingestion. Hunger ratings differed significantly between individuals but not between groups. However, only Pi had significantly elevated hunger ratings in the end of the test period compared to their initial ratings. In anticipation of the meal a significant change in blood glucose was observed between the groups (P = 0.05), where values dropped for Pi and rose for F. Four out of five subjects in F and one subject in Pi were considerably hungrier during time periods they reported as habitual eating occasion. Conclusion Correlations between absolute blood glucose levels and hunger could not be found. An equal rise in hunger appear regardless if subjects were fed or fasting, meaning significant hunger can appear although dietary energy still is absorbed into the blood stream. Thus our results indicate that the acute availability of dietary energy is only a relatively small part of the total hunger signaling process. A disrupted meal pattern seemed to affect hunger feelings more than the ingestion of the served meal. Thus we conclude that more research should focus on meal-pattern regulation to enable better hunger control.

APA, Harvard, Vancouver, ISO, and other styles

3

Chin-Chen, Wu, and 吳金珍. "Effects of Eleutherococcus senticosus on Blood Lipid, Fasting Blood Sugar and Antioxidant Status in Type 2 DM Patients." Thesis, 2006. http://ndltd.ncl.edu.tw/handle/33548432406871629542.

Full text

Abstract:

碩士<br>輔仁大學<br>食品營養學系<br>94<br>Diabetes Mellitus (DM) is one of the top ten lethal diseases in Taiwan. Recent studies showed that DM and its complications might have been related to blood lipid and oxidative stress. Thus, benefits of Eleutherococcus senticosus (ES) in reducing blood lipid, blood sugar and antioxidant status is a topic to be concerned. This study aims to evaluate the effect of ES on blood lipid, fasting blood sugar and antioxidant status in type 2 DM patients. Experimental test were designed in double-blinded, cross-over methods. Nine type 2 DM patients (55±10 yrs) were treated with ES or placebo capsule 1200 mg/D for 8 weeks. Blood samples collected before and after the treatment. These samples will be analyzed for: (1) fasting blood sugar (FBS) (2) Blood lipid, which the indicators include total cholesterol (TC), triglyceride (TG), high density lipoprotein (HDL), low density lipoprotein (LDL) (3) antioxidative enzyme activities, which included glutathione peroxidase (GPX), glutathione reductase (GRd), superoxide dismutase (SOD), and catalase (CAT) (4) lipid peroxidation products, which is malondialdehyde (MDA).(5) Liver and kidney function index, which included glutamate oxaloacetate transaminase (GOT), glutamate pyruvate transaminase (GPT), blood urea nitrogen (BUN) and creatinine. Statistics analysis used paired t-test. Results showed ES can significantly reduced fasting blood sugar (p＜0.05), reduced TG, MDA and increase antioxidant status (SOD, CAT and GRd activity).

APA, Harvard, Vancouver, ISO, and other styles

4

"Effect of Curcuma Longa (Turmeric) on Postprandial Glycemia in Healthy, Non-diabetic Adults." Master's thesis, 2017. http://hdl.handle.net/2286/R.I.44237.

Full text

Abstract:

abstract: Curcumin is an active ingredient of Curcuma longa (Turmeric) and is studied extensively for its antioxidant, anti-inflammatory, anti-bacterial, anti-viral, and anti-cancer properties. The purpose of this study was to examine the effects of turmeric on blood glucose and plasma insulin levels. The study utilized a placebo-controlled, randomized cross-over design with participants serving as their own control. Eight glucose tolerant healthy participants completed the full study. Three-weeks washout period was kept in between six-weeks. Prior to the test meal day, participants were asked to eat a bagel with their evening dinner. During the day of the test meal, participants reported to the test site in a rested and fasted state. Participants completed mashed potato meal tests with 500 mg of turmeric powder or placebo mixed in water, followed by 3 weeks of 500 mg turmeric or placebo supplement ingestion at home. During this visit blood glucose finger picks were obtained at fasting, 30, 60, 90, and 120 min post-meal. Blood plasma insulin at fasting and at 30 min after the test meal were also obtained. During week 4, participants reported to the test site in a rested and fasted state where fasting blood glucose finger pricks and blood plasma insulin were measured. During week 5 to 7, participants were given a washout time-period. During week 8, entire process from week 1 to 4 was repeated by interchanging the groups. Compared to placebo, reduction in postprandial blood glucose and insulin response were non-significant after ingestion of turmeric powder. Taking turmeric for 3 weeks had no change in blood glucose and insulin levels. However, taking turmeric powder supplements for 3 weeks, showed a 4.4% reduction in blood glucose. Change in insulin at 30 min were compared with baseline insulin level showing no significant change between placebo and turmeric group. Fasting insulin after 3-weeks consumption of turmeric did not show any significant change, but showed a larger effect size (0.08). Future research is essential to examine the turmeric powder supplement benefits over a long period of time in healthy adults and whether it is beneficial in preventing the occurrence of type 2 diabetes.<br>Dissertation/Thesis<br>Masters Thesis Nutrition 2017

APA, Harvard, Vancouver, ISO, and other styles

5

Magistrelli, Ashley M. "Effects of ground cinnamon on postprandial blood glucose levels between obese and normal weight individuals." 2010. http://liblink.bsu.edu/uhtbin/catkey/1607094.

Full text

Abstract:

The purpose of this project was to determine the effects of 6 g of ground cinnamon added to farina (Cream of Wheat) cereal on blood glucose levels between obese and normal weight individuals. Thirty students, aged 19-30 years, were recruited to participate in this study. During study visits, participants were given one of two test meals (74 g of farina with and without 6 g of cinnamon) followed by seven blood glucose measurements over a two-hour period. A significant difference was seen in glycemic response between the two dietary conditions, but not between the two BMI groups (normal and obese). The two BMI groups were combined for analysis of dietary conditions. Ingestion of the cinnamon cereal resulted in significantly lower blood glucose responses at minutes 15, 30, 45 and 60 compared to the plain cereal. The results of this study confirm the positive glucose-lowering effects of cinnamon.<br>Department of Family and Consumer Sciences

APA, Harvard, Vancouver, ISO, and other styles

6

Kitenge, Tshibwila Gabin. "The prevalence of impaired glucose tolerance, impaired fasting glucose and undiagnosed type 2 diabetes among middle aged adults attending the outpatiets department at the Professor Z K Matthews Hospital, Barkley West, Northern Cape Province; South Africa." Thesis, 2014. http://hdl.handle.net/10386/1337.

Full text

Abstract:

Thesis (MPH.) -- University of Limpopo, 2014<br>Objective: The purpose of this study was to determine the prevalence of impaired glucose tolerance, impaired fasting glucose, undiagnosed type 2 diabetes and its associated risk factors among adults patients attending the outpatient department of a level one hospital in a rural community of Barkley West, South Africa. Research methodology: This was a cross-sectional survey conducted by a simple random sampling of adults patients F 30 years old. Patients were screened using the American Diabetes Association and the World Health Organisation criteria. First, patients underwent the 75g oral glucose tolerance test and secondly, the 12-hours fasting plasma glucose tests after pre-test results of 5.5 mmol/L were obtained considered as positive for screening. To determine the prevalence of IGT, IFG, and undiagnosed type 2 diabetes; tests were conducted using both the capillary finger puncture and the laboratory methods. To ensure validity and reliability, each patient underwent two tests (fasting and random) by the capillary finger puncture method and two tests (fasting and random) by the laboratory method. Results: Eighty-five (85) questionnaires were distributed, supervised and returned by a research assistant, which brought the response rate to 100%. All patient known living with diabetes mellitus was not included in the study. The prevalence of IGT was 34.1% [34% for females and 9.4% for males] and that for IFG was 23.6% [25% for females and 6.0% for males]. The prevalence of undiagnosed type 2 diabetes discovered during the survey was 9.3% by 2-hours 75g glucose tolerance test [8.2% for females and 1.1% for males] and that by 12-hours fasting plasma glucose, the prevalence was 5.8% [4.7% for females and 1.1% for males].The associated risk factors were physical inactivity, overweight and obesity, unhealthy diet, alcohol consumption, hypertension, smoking habit, family history of diabetes, social deprivation and poverty. The prevalence of hyperglycaemia was also high among female patients due to a higher BMI with 25% overweight (females 18% overweight, males 7% overweight) and 75% obese (females 54% of obesity, males 21% of obesity); higher waist circumference with higher abdominal fat (females 71.7% had a W/C F 88 cm, males 28% had a W/C F 102 cm.); and a larger waist-to-hip ratio (females 61.1% had WHR > 0.85, males 7% had a WHR > 1.0). The sensitivity, specificity, positive and negative predictive values for IGT were 34%, 86%, 25%, and 86% and those for IFG were 24%, 86%, 19%, and 86% respectively. IGT sensitivity was greater than IFG sensitivity. xi Conclusion: There was a high prevalence of IGT, IFG and undiagnosed type 2 diabetes specifically among female patients. The ten percent difference of sensitivity between the two tests showed that the WHO diagnostic criteria produced more patients with the pathology than the ADA diagnostic criteria do. Patients attending the outpatient department of a level one hospital in Barkley West are at high risk of developing type 2 diabetes and remain unidentified, undetected, unscreened, undiagnosed and untreated. Obesity at primary health care level in the rural community of Barkley West needs to be addressed. . Keywords: Impaired glucose tolerance, prevalence, diabetes, screening, anthropometric measurements

APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Fasting Blood Sugar; Postprandial Blood Sugar"

1

Pasqualina, Santaguida, United States. Agency for Healthcare Research and Quality., and McMaster University. Evidence-based Practice Center., eds. Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose. Agency for Healthcare Research and Quality, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Portales, Allegra. Fasting Blood Sugar Chart : How to Control Prediabetes: Non Fasting Blood Sugar. Independently Published, 2021.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Lade, Marti. Fasting Blood Sugar High : How to Lower Fasting Blood Sugar: How to Reverse Prediabetes. Independently Published, 2021.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

fatima, kajjout. Blood Pressure Log for Your Daily Measurements &fasting Blood Sugar. Independently Published, 2020.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Villaplana, Sydney. Fasting Blood Sugar : How Long Does It Take to Reverse Prediabetes: Signs of Prediabetes. Independently Published, 2021.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

JONES, E. V. A. Intermittent Fasting for Diabetics: New Doctors Approved Fasting and Dietary Guide to Prevent, Manage and Reverse Diabetes, Lower Your Blood Sugar Level with Effective Low Sugar Recipes. Independently Published, 2021.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Healthy Intermittent Fasting for Diabetics: Delicious Dietary Diet Recipes to Keep Blood Sugar and Diabetics under Control. Independently Published, 2020.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Lisa, James. Intermittent Fasting for Diabetics: The User-Friendly Methods with Recipes to Reverse Diabetes, Regulate Blood Sugar, Lose Weight, Reset Metabolism and Heal Your Body. Independently Published, 2022.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Longer, Melisa. Intermittent Fasting For Women Over 50: How to Lose Weight and Lower Blood Sugar Levels - The Ultimate And Complete Guide To Learn How To Eat Healthily. Melisa Longer, 2021.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Afifi, Ahmed. From 10 to 5 My Journey with Diabetes: How I Normalized My Blood Sugar. Thoughts about T1, T2 Diabetes Management, Low Carb, Obesity, Fasting, Cholesterol and More. Independently Published, 2019.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Fasting Blood Sugar; Postprandial Blood Sugar"

1

Alp, Harun. "Antidiabetic Phytotherapy." In Current Perspective on Diabetes Mellitus in Clinical Sciences. Nobel Tip Kitabevleri, 2023. http://dx.doi.org/10.69860/nobel.9786053359111.40.

Full text

Abstract:

Phytotherapy, or the use of plant-based substances for medicinal purposes, has gained attention in the management of diabetes mellitus (DM) due to its potential benefits and fewer side effects compared to conventional medications. Various plant extracts and herbal remedies have been studied for their antidiabetic properties, with mechanisms including enhancement of insulin secretion, improvement of insulin sensitivity, inhibition of carbohydrate digestion and absorption, and antioxidant effects. Commonly studied plants include bitter melon (Momordica charantia), fenugreek (Trigonella foenum-graecum), cinnamon (Cinnamomum verum), and ginseng (Panax ginseng). Bitter melon, for instance, contains compounds that mimic insulin and may help regulate blood sugar levels. Fenugreek seeds have shown promise in reducing blood glucose levels and improving insulin sensitivity. Cinnamon extracts have been reported to lower fasting blood sugar levels by improving insulin signaling and glucose transport.While phytotherapy offers potential benefits, it’s crucial to note that scientific evidence supporting their efficacy and safety is still evolving. Standardization of dosage, potential interactions with medications, and variability in bioactive compounds among plant sources are important considerations. Therefore, individuals considering phytotherapy for diabetes management should consult healthcare professionals to ensure safe and effective integration with conventional treatments and monitoring of blood glucose levels.

APA, Harvard, Vancouver, ISO, and other styles

2

Nadiroh, ‘Ulayya Azzah, Sulistyani Sulistyani, Rizky Febrian, and Oxa Aqilla Putri Suharyono. "The Relationship Between Fasting Blood Sugar Levels and Waist Circumference with Cognitive Function in Diabetes Mellitus Patients." In Advances in Health Sciences Research. Atlantis Press International BV, 2023. http://dx.doi.org/10.2991/978-94-6463-184-5_3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Suharyono, Oxa Aqilla Putri, Iin Novita Nurhayati Mahmuda, Rizky Febrian, and ‘Ulayya Azzah Nadiroh. "Correlation Between Age, Gender, and Fasting Blood Sugar Levels with Peripheral Artery Disease Incidence in Patients with Type 2 Diabetes Mellitus." In Advances in Health Sciences Research. Atlantis Press International BV, 2023. http://dx.doi.org/10.2991/978-94-6463-184-5_2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Sawitzki, Franciellen, and Marcelo Augusto Mendes da Silva. "Glycemic response of coconut sugar, sucrose and brown sugar in healthy subjects." In UNITING KNOWLEDGE INTEGRATED SCIENTIFIC RESEARCH FOR GLOBAL DEVELOPMENT. Seven Editora, 2023. http://dx.doi.org/10.56238/uniknowindevolp-014.

Full text

Abstract:

Diabetes mellitus is a disorder in which blood sugar (glucose) levels are abnormally high because the body does not produce enough insulin to meet its needs. The world population with Diabetes mellitus is estimated to be about 387 million and may reach 471 million in 2035. Diabetes is, therefore, considered to be the most common endocrine disease. There is significant evidence supporting the idea of interventions to improve diabetes outcomes, one of them is glycemic control in the basic nutrition. Coconut sugar (Cocos nuciferas. L.), has been marketed with the promise of having a low glycemic index and recommended for diabetic patients. This research's objective was to compare the glycemic response of 30 healthy volunteers in 4-hour fasting after the intake of coconut sugar, sucrose and brown sugar, ranging in age from 19 to 50 years, being 73% female and 27% male, who were randomly divided into three distinct groups with the intake of 50g of the respective sugars. Capillary blood glucose was measured in times: 0; 15; 30; 45 and 60 minutes. The data was evaluated using the analysis of variance, and the Scott-Knott test was chosen to verify the differences in results. We conclude that the three kinds of sugars presented statistically the same behaviors (p <0.05) regarding the increase of glycemia in times 15, 30 and 60 minutes in relation to time zero, there was a significant difference (p <0.05) in the time of 45 minutes, where a longer time for the coconut sugar decrease occurred. However, it is concluded that coconut sugar behaves similarly to the other sugars, and should be re-evaluated as a product that has a low glycemic index.

APA, Harvard, Vancouver, ISO, and other styles

5

Kjærgaard Thorsen, Mille, and Anne Line Dalsgård. "Chapter 11. Balancing Blood Sugar: Fasting, Feeling, and Time Work during the Egyptian Ramadan." In Time Work. Berghahn Books, 2022. http://dx.doi.org/10.1515/9781789207057-012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Salam, Muhammad, and James Sowers. "Case 84: Postprandial Hypoglycemia, an Uncommon Presentation of Type 2 Diabetes." In Diabetes Case Studies: Real Problems, Practical Solutions. American Diabetes Association, 2015. http://dx.doi.org/10.2337/9781580405713.84.

Full text

Abstract:

A 52-year-old white man presented to his primary care physician with neurogenic symptoms (sweating, palpitations, headache) accompanied by capillary blood glucose levels in the 40–60 mg/dL range. The symptoms would always occur 1–2 h after a meal and would resolve with ingestion of a sugar source (e.g., orange juice, regular soda). There was no history of neuroglycopenic symptoms (confusion, loss of consciousness, seizure) during any of these episodes. Patient’s prior history was notable for hypertension, hyperlipidemia, and gastroesophageal reflux disease (GERD). Physical examination was remarkable for central obesity with a BMI of 32 kg/m2.

APA, Harvard, Vancouver, ISO, and other styles

7

Mrvichin, Nate, Gilbert R. Kaats, Debasis Bagchi, and Harry G. Preuss. "Evaluating proposed surrogates to estimate insulin resistance in non-diabetics: emphasizing the ratio triglycerides/HDL-cholesterol versus fasting blood glucose." In Dietary Sugar, Salt and Fat in Human Health. Elsevier, 2020. http://dx.doi.org/10.1016/b978-0-12-816918-6.00013-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Preuss, Harry G., Nate Mrvichin, Debasis Bagchi, and Gilbert R. Kaats. "Linking fasting blood glucose quartiles of nondiabetic volunteers ages 21–84 years to metabolic syndrome components: focusing on the aging paradox." In Dietary Sugar, Salt and Fat in Human Health. Elsevier, 2020. http://dx.doi.org/10.1016/b978-0-12-816918-6.00017-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Lema-Pérez, Laura. "Main Organs Involved in Glucose Metabolism." In Sugar Intake - Risks and Benefits and the Global Diabetes Epidemic. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.94585.

Full text

Abstract:

Sugar, or technically known as glucose, is the main source of energy of all cells in the human body. The glucose homeostasis cycle is the mechanism to maintain blood glucose levels in a healthy threshold. When this natural mechanism is broken, many metabolic disorders appear such as diabetes mellitus, and some substances of interest, like glucose, are out of control. In the mechanism to maintain blood glucose, several organs are involved but the role of most of them has been disregarded in the literature. In this chapter, the main organs involved in such a mechanism and their role in glucose metabolism are described. Specifically, the stomach and small intestine, organs of the gastrointestinal system, are the first to play an important role in the regulatory system, because it is where carbohydrates are digested and absorbed as glucose into the bloodstream. Then glucose as a simple substance goes to the liver to be stored as glycogen. Glucose storage occurs due to the delivery of hormones from the pancreas, which produces, stores, and releases insulin and glucagon, two antagonistic hormones with an important role in glucose metabolism. The kidneys assist the liver in insulin clearance in the postprandial state and gluconeogenesis in the post absorptive state. Physiological aspects and the detailed role of every organ involved in glucose metabolism are described in this chapter.

APA, Harvard, Vancouver, ISO, and other styles

10

Noo-In, Supattra, Thidarat Somdee, Chitkamon Srichompoo, and Santisith Khiewkhern. "The Effects of Health Behavior Changing Program for Systolic Blood Pressure Reduction Among Thai Buddhist Monks, Thailand." In Studies in Health Technology and Informatics. IOS Press, 2022. http://dx.doi.org/10.3233/shti220695.

Full text

Abstract:

Thai Buddhist monks’ lifestyle has made them likely to get non-communicable diseases. Therefore, the Ministry of Public Health of Thailand has conducted a health behavior-changing program for non-communicable diseases prevention among Thai Buddhist monks. This study aims to examine the effectiveness of the health behavior-changing Program for Non- communicable diseases prevention among 4,786 Thai Buddhist monks who were risk group. They were on the program for 6 months. from January 1st, 2021 to June 30th, 2021. Descriptive statistics were used to describe the characteristics of the subjects and Paired t-test was used to compare the mean difference. The results showed that the health behavior-changing program can reduce Fasting Blood Sugar, Body Mass Index, Risk score, Hypertension, and Smoking scores. Therefore, this program should be used for reducing risk factors of non-communicable diseases among Thai monks in the Upper Northeast region of Thailand.

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Fasting Blood Sugar; Postprandial Blood Sugar"

1

"Serum Triglyceride, Cholesterol and Fasting Blood Sugar in Male Rats Exposed to Oil Paint Vapor." In International Conference on Earth, Environment and Life sciences. International Institute of Chemical, Biological & Environmental Engineering, 2014. http://dx.doi.org/10.15242/iicbe.c1214105.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Kadhim Al-Shemery, Maryam. "ST2 Concentration as Cardiac Biomarker in Cvd Patients with Hyperglycemia." In XII. International Scientific Congress of Pure, Applied and Technological Sciences. Rimar Academy, 2024. https://doi.org/10.47832/minarcongress12-23.

Full text

Abstract:

Background: During vascular remodeling, fibrosis, including damage to the myocardium, ST2 is crucial. Since their development, high-sensitivity persistent Inhibition of Tumor formation-2 (sST2) tests have proven to provide useful tools in the diagnosis and surveillance for cardiovascular disorders. . Objectives: The research presented here aims to improve existing comprehension of sST2 in cardiovascular illness, particularly a focus upon the connection underlying hypoglycemia as well as The ST2. Materials and methods: The region of Al-Najaf el-Ashraf's Hospital Al Sader General Teaching was used as the investigation's site. A collection mainly sixty individuals were analyzed, comprising of thirty-five individuals who had cardiovascular disease (CVD) with twenty-five healthy. The median age of the patients was 35 to 65. Age, creatinine, urea, fasting glucose level, the random blood sugar levels in patients having Cardiovascular have been assessed for the research patients. This investigation additionally confirmed the individual's ST2 levels. Result: The results of the investigation show that, as compared to controls, those suffering from Cardiovascular had substantially greater levels of ST2, urea, which and creatinine levels, as well as arbitrary blood sugar and fasting glucose levels. In the research subjects, this genetic marker showed an upward trend with both creatinine and (fasting glucose and random blood sugars). Conclusions: Individuals having Cardiovascular died at increased rates when their circulation ST2 content was increased. Kinase ST2 is positively regulated by hypoglycemia. Thus, in patients with CVD, there is a correlation between ST2 level increasing the incidence of diabetes. According to what we have discovered, there's is a highly substantial clinical correlation between ST2 with kidney problems

APA, Harvard, Vancouver, ISO, and other styles

3

Saro, Nikmah, Veni Hadju, and Atjo Wahyu. "Correlation Between Nutritional Behavior and Lipid Profile and Fasting Blood Sugar of State secondary school Teachers Having Central Obesity in Makassar City." In the International Conference. ACM Press, 2018. http://dx.doi.org/10.1145/3242789.3242813.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Amelia, Rina, Juliandi Harahap, Aznan Lelo, Reni Asmara Ariga, and Novita Sari Harahap. "Effect of Physical Activity on Fasting Blood Sugar Level, HbA1c and Total Cholesterol among Type 2 Diabetes Mellitus Patients in Medan City, Indonesia." In International Conference of Science, Technology, Engineering, Environmental and Ramification Researches. SCITEPRESS - Science and Technology Publications, 2018. http://dx.doi.org/10.5220/0010077205280533.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Rahayu, Ijah, Veni Hadju, and Ridwan M. Thaha. "Correlation Between Life Style and Dyslipidemia with Impaired Fasting Blood Sugar in State Junior High School and State Senior High School Having Central Obesity." In the International Conference. ACM Press, 2018. http://dx.doi.org/10.1145/3242789.3242811.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Yulianti, Kartika, Aris Wibudi, and Mila Citrawati. "Relation Between Tiroid Status with Glycemic Control of Type 2 DM Patients at RSPAD Gatot Soebroto." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.05.12.

Full text

Abstract:

ABSTRACT Background: Diabetes Mellitus (DM) is a group of symptoms that arise due to increased blood sugar levels. Diabetes Mellitus type 2 has a higher risk of developing thyroid dysfunction. Thyroid dysfunction can affect various body metabolism and result in insulin resistance, significantly affecting glycemic control in DM patients. This study aimed to determine the relation between thyroid status as assessed by the level of thyroid-stimulating hormone (TSH), free thyroxine (FT4), and glycemic control (HbA1c). Subjects and Method: A cross-sectional study. A sample of 38 DM patients was selected by purposive sampling. The dependent variable was glycemic control. The independent variables were TSH and FT4. Patients were classified into 4 quartiles (Q) based on their TSH and FT4 levels. Statistic test used was non parametric for category group of variables, which was Chi square test. Results: Mean of fasting blood glucose was 200,56 mg/dL (modus 137 mg/dL), mean of 2 hours post prandial blood glucose was 247 mg/dL (modus 305 mg/dL). Subjetcs with poor glycemic control dominated as much as 76%. Most subjects had TSH level at Q4 (36%), while most of the subjects had FT4 level at Q1 (34%). The results showed that 38 samples with poor glycemic control were 72% in the 4th quartile (Q4) (> 3.1750 mU / L) TSH, and 64.7% were in Q1 (≤ 11.8400) FT4. The analysis showed that there was a significant relation between TSH (p = 0.047) and FT4 (p = 0.041) with glycemic control in type 2 DM patients. Conclusion: FT4 and TSH levels relate to glycemic control in type 2 DM patients Keywords: TSH, FT4, HbA1c, Diabetes Mellitus Correspondence: Mila Citrawati. Department of Faal, Faculty of Medicine, UPN Veteran, Jakarta. Jl. RS Fatmawati, Pondok Labu, South Jakarta 12450, Telp. (021) 7656971. E-mail: milacitrawati@upnvj.ac.id. Mobile: 081282990515 DOI: https://doi.org/10.26911/the7thicph.05.12

APA, Harvard, Vancouver, ISO, and other styles

7

Owosela, Kingsley. "Reversal of Type 2 Diabetes Using Nutrition and Lifestyle Interventions." In SPE International Health, Safety, Environment and Sustainability Conference and Exhibition. SPE, 2024. http://dx.doi.org/10.2118/220250-ms.

Full text

Abstract:

Abstract Background The worldwide prevalence and burden of Type 2 diabetes mellitus (T2DM) keeps growing at a frightening rate and uncontrolled diabetes has become one of the most common reasons for restricted fitness to work in the oil and gas industry. Based on the 2021 International Diabetes Federation's statistics, MENA Region has the highest regional prevalence of 16.2% and is expected to reach 31% by 2045 (IDF, 2021). Type 2 diabetes has long been classified as an irredeemable chronic metabolic disease based on the standards of care treatment approach. The best outcome expected has been the improvement of symptoms or slowing the predictable consequences of diabetes. Although traditional view has been that diabetes is irredeemable and unstoppable, the paradigm is changing. Evidence from numerous studies show that type 2 diabetes remission and reversal is possible through health education, low-carb Mediterranean diet and other lifestyle interventions. Aim The purpose of this retrospective study was to assess the effectiveness of our company's diabetes program on glycated hemoglobin (HbA1c), body weight, and fasting blood sugar (FBS) for the remission or reversal of Type 2 Diabetes. Methods The study involved 106 employees with T2DM within the age range of 21 to 60 years and HbA1c value between 7.0% to 14.0%. The participants were assigned holistic diabetes expert doctors that provided tailored holistic nutrition, sustainable fitness, and counseling/behavioral modification/education to reverse T2DM. Lab values of FBS, HbA1c, and body weight of the patients were recorded at the start and the end of the study. The determine the efficacy of the program, we compared the results in the program to that of a control group with 73 individuals diagnosed with T2DM and treated with diabetes pharmaceuticals but not part of the company's diabetes program. Results After analysis (mean ± SD), a substantial reduction in FBS, HbA1c, and body weight was observed in the program participants in comparison to the control. Based on the results HbA1c decreased from 10.5 ± 1.3% to 5.7 ± 1.0% with a mean drop of 4.8±1.2%; FBS reduced from 195.1 ± 53.4 mg/dL to 93.2 ± 18.8 mg/dL with an average FBS reduction of 101.9 ± 45.3 mg/dL, and body weight dropped from 89.8 ± 11.2 kg to 74.6 ± 11.8 kg with a mean loss of 15.2 kg. Conclusion These results demonstrate that a holistic diabetes care program involving individualized holistic nutrition, sustainable exercise training, counseling, lifestyle behavioral modification, and education similar to our diabetes program, can help to improve and sustain a healthy blood sugar status and body weight in individuals with T2DM. In comparison to the aforementioned MENA region prevalence of 16.2% and the company's prevalence of 13.4% in 2019, the prevalence now stands at 3.2%.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!